Bixiye
QP49-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2024
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2024
Natiijooyinka Raadinta
Soo bandhiga 1151 - 1160 ee natiijooyinka 3688
Bixiye
P32-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Bixiye
P31-24 2024 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Bixiye
P2R1-24 New 2024 Practitioner Credentialing Requirements Delayed Indefinitely
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Bixiye
P29-24 2024 Renewal Changes Summary for Suppliers of Durable Medical Equipment (DME)
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Bixiye
P30-24 2024 Renewal Changes Summary for Aware Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Bixiye
P28-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Laboratory Management Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Dukaamaysiga & Barashada
2024-quality-program-overview.pdf
Bixiye
QP30-24 Update for New to Market Medical Drugs: prademagene zamikeracel and marnetegragene autotemcel
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
QP33-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective May 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024